| <SPAN style=FONT-SIZE: 13px; FONT-FAMILY: myFirstFont; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(33,37,41); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial>The equity shares of Mahamaya Lifesciences (Scrip Code: 544611) are listed effective 18 November 2025 and admitted to dealings on the Exchange in the list of ''MT'' group securities. At 10:07 IST, the stock was trading at a premium of 1.75% to the issue price of Rs 114. </SPAN> |